Sedana Medical has carried out a primary issuance of shares of approximately SEK 615 million at a subscription price of SEK 86 per share. The subscription price was determined through an accelerated book-building procedure. 

Sedana Medical AB, founded in 2005, is a medtech and pharmaceutical company focused on  inhaled sedation to improve the patient’s life during and beyond sedation.

Pareto Securities acted as sole manager and bookrunner. Baker McKenzie acted as legal advisor to Pareto Securities with an international capital markets team consisting of Joakim Falkner and Stefan Balazs in Stockholm as well as Adam Farlow and Charles Farnsworth in London.

Explore Our Newsroom